Goldman Sachs’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
58,653
+24,427
| +71% | +$272K | ﹤0.01% | 4110 |
|
|
2025
Q1 | $421K | Sell |
34,226
-8,057
| -19% | -$99K | ﹤0.01% | 4348 |
|
|
2024
Q4 | $473K | Buy |
42,283
+19,857
| +89% | +$222K | ﹤0.01% | 4325 |
|
|
2024
Q3 | $156K | Sell |
22,426
-1,522
| -6% | -$10.6K | ﹤0.01% | 4545 |
|
|
2024
Q2 | $181K | Sell |
23,948
-115,895
| -83% | -$876K | ﹤0.01% | 4392 |
|
|
2024
Q1 | $1.85M | Buy |
+139,843
| New | +$1.85M | ﹤0.01% | 3253 |
|